Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
出版年份 2013 全文链接
标题
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
作者
关键词
-
出版物
Cell Death & Disease
Volume 4, Issue 6, Pages e688-e688
出版商
Springer Nature
发表日期
2013-06-21
DOI
10.1038/cddis.2013.207
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
- (2014) K. Nagahara et al. JOURNAL OF IMMUNOLOGY
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
- (2012) S. Jube et al. CANCER RESEARCH
- Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
- (2012) Yoshiyuki Suzuki et al. CANCER RESEARCH
- Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
- (2012) Hye Won Chung et al. CANCER SCIENCE
- On the armament and appearances of human myeloid-derived suppressor cells
- (2012) Isabel Poschke et al. CLINICAL IMMUNOLOGY
- High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
- (2012) Wei Yan et al. HEPATOLOGY
- HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
- (2012) Clarissa Anni Wild et al. INTERNATIONAL IMMUNOLOGY
- Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients
- (2012) Yvonne Nadine Fahmueller et al. INTERNATIONAL JOURNAL OF CANCER
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Tumor immunity times out: TIM-3 and HMGB1
- (2012) Daolin Tang et al. NATURE IMMUNOLOGY
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
- (2012) Clarissa A. Wild et al. ORAL ONCOLOGY
- Regulatory T Cells in γ Irradiation-Induced Immune Suppression
- (2012) Hugh I. McFarland et al. PLoS One
- Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
- (2012) Hanna Lee et al. PLoS One
- Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
- (2012) Oliver J. Stoetzer et al. TUMOR BIOLOGY
- Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment
- (2012) Masahisa Jinushi OncoImmunology
- Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
- (2012) Mickaël Michaud et al. OncoImmunology
- Abscopal but desirable
- (2012) Guido Kroemer et al. OncoImmunology
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- Prognostic Impact of ΔTAp73 Isoform Levels and Their Target Genes in Colon Cancer Patients
- (2011) Beatriz Soldevilla et al. CLINICAL CANCER RESEARCH
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
- (2010) D. Mougiakakos et al. BLOOD
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
- (2010) L. Zitvogel et al. CLINICAL CANCER RESEARCH
- Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance
- (2010) Yong Liu et al. EUROPEAN JOURNAL OF CANCER
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
- (2009) Hye Chung et al. Journal of Translational Medicine
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death
- (2008) D. Mougiakakos et al. BLOOD
- Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies
- (2008) L. Apetoh et al. CANCER RESEARCH
- Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma
- (2008) Yoshiki Mizukami et al. CANCER SCIENCE
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
- The immunogenicity of tumor cell death
- (2008) Oliver Kepp et al. CURRENT OPINION IN ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started